Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
2.
Clin Case Rep ; 6(1): 68-70, 2018 01.
Article in English | MEDLINE | ID: mdl-29375840

ABSTRACT

We investigated the effect of oral care on the prevention of pneumonia using a clinical scoring scale in elderly patients with psychiatric disorders after the withdrawal of nasogastric feeding tubes. Notably, oral care was effective in preventing pneumonia relapse in these patients.

4.
Jpn Clin Med ; 8: 1179670717720407, 2017.
Article in English | MEDLINE | ID: mdl-28811746

ABSTRACT

PURPOSE: Oral care in hospitalized patients with psychiatric disorders is important. However, some patients with psychiatric disorders cannot undergo oral care because of psychiatric symptoms and cognitive decline. The effect of a standardized oral hygiene intervention on the prevention of pneumonia in hospitalized patients with psychiatric disorders was investigated. METHOD: Patients were divided into 2 groups: control group (N = 259), patients without standardized intervention who were enrolled on April 2014 as the time point of baseline, and intervention group (N = 263), patients with standardized intervention who were enrolled on April 2015 as the time point of baseline. Two end points were evaluated: (1) pneumonia onset within 1 year after the enrollment and (2) no pneumonia for 1 year after the enrollment. The following parameters were compared between the groups: sex, age, psychiatric disorders, past history of diseases of the respiratory system, hypertension, diabetes, hyperlipidemia, heart impairment, and pneumonia. RESULTS: No statistically significant differences were found between the 2 groups in the distributions of characteristics except pneumonia by univariate analysis. The presence of pneumonia was significantly associated with age and the absence of the standardized oral hygiene intervention by multivariate logistic regression analysis. CONCLUSIONS: The standardized oral hygiene intervention appears to be effective for preventing pneumonia in patients with psychiatric disorders.

6.
Psychogeriatrics ; 10(4): 198-200, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21159055

ABSTRACT

The aim of the present study was to determine the efficacy, side-effects and tolerability of blonanserin for treating refractory behavioural psychological symptoms of dementia (BPSD). The present study was a 12-week, prospective, structured clinical trial of blonanserin for the treatment of BPSD. The degree of cognitive function, activities of daily living score, and the degree of BPSD were determined using the Mini-Mental State Examination (MMSE), Disability Assessment for Dementia (DAD), Neuropsychiatric Inventory (NPI) and the Rating Scale for Aggressive Behaviour in the Elderly (RAGE). The severity of extrapyramidal symptoms was assessed using the Drug-Induced Extrapyramidal Symptoms scale (DIEEPS). Five patients were enrolled. These patients met the NINCDS-ADRDA criteria. The patients were prescribed more than two kinds of existing antipsychotic drugs and were considered refractory cases; the drugs were discontinued because they were ineffectual and side-effects appeared. Each drug was prescribed independently for at least 2 weeks. The mean changes (at baseline and at the last week, respectively) in the MMSE (12.25, 9.25), in the DAD (6.5, 6.75), in the RAGE (5.5, 5.3) and in the DIEEPS (0.5, 1.5) were minimal. The mean changes in the NPI were two or fewer points. Some side-effects (one gait abnormality and one pneumonia) were observed. The results of this preliminary study show that blonanserin does not have adequate efficacy for the treatment of refractory BPSD.


Subject(s)
Alzheimer Disease/drug therapy , Dopamine D2 Receptor Antagonists , Mental Disorders/drug therapy , Piperazines/therapeutic use , Piperidines/therapeutic use , Receptor, Serotonin, 5-HT2A/drug effects , Aged , Aged, 80 and over , Aggression/drug effects , Alzheimer Disease/diagnosis , Alzheimer Disease/psychology , Basal Ganglia Diseases/chemically induced , Basal Ganglia Diseases/diagnosis , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Resistance , Female , Humans , Japan , Male , Mental Disorders/diagnosis , Mental Disorders/psychology , Mental Status Schedule/statistics & numerical data , Neuropsychological Tests/statistics & numerical data , Piperazines/adverse effects , Piperidines/adverse effects , Prospective Studies , Psychometrics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...